C

Connect Biopharma Holdings Limited
D

CNTB

2.10000
USD
-0.04
(-1.87%)
مغلق
حجم التداول
3,545
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
132,224,091
المقالات
المزيد

العنوان: Connect Biopharma Holdings Limited

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.